Catalyst Wire Dossier Catalyst Wire Dossier

Cisplatin/Gemcitabine

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Cisplatin/Gemcitabine, covering 2022-03-24 to 2023-03-24. Get the full timeline:

Most recent: Clinical Trial Update: MILES-3: Cisplatin in Combination With Gemcitabine for Elderly Patients With Lung Cancer [Phase 3]

See pricing